• MarketWatch
    MarketWatch wrote a new blog entry:
    A career-focused platform for jobs, talent di...
    Visit my website
    · 1 hour ago ·
    ‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
    ‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
    The controversial investor has been weighing in on biopharma stocks even though he’s banned from doing so.

More from the community

Browse all community posts →